• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌中的跳跃式转移——患病率、预测因素和临床病理因素。

Skip Metastases in Papillary Thyroid Carcinoma - Prevalence, Predictive and Clinicopathological Factors.

机构信息

1Department of Ear, Nose, Throat, and Head and Neck Surgery, Zagreb University Hospital Centre; 2School of Medicine, University of Zagreb.

出版信息

Acta Clin Croat. 2020 Jun;59(Suppl 1):122-128. doi: 10.20471/acc.2020.59.s1.16.

DOI:10.20471/acc.2020.59.s1.16
PMID:34219894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8212598/
Abstract

BACKGROUND

Cervical lymph node metastases are frequently found in papillary thyroid carcinoma (PTC) and occur in a stepwise fashion. Skip metastases that omit the central compartment and spread initially in lateral neck levels are present in a certain share of patients, and their significance is poorly understood. The aim of this prospective study was to identify their possible predictors and clinicopathological factors in a group of patients with PTC with lateral lymph node (LLN) metastases.

METHODS

We enrolled 68 patients with PTC with preoperatively evaluated LLN metastases who underwent total thyroidectomy with lateral lymph node dissection between 2011 and 2018. We analysed the clinicopathological features and pattern of dissemination of continuous and skip metastases.

RESULTS

The prevalence of skip metastases was 23.5%. Compared with the continuous metastases group, the patients were older, had primary tumors that were more often situated unilaterally, and had smaller primary tumor size. Level II was less often involved, and none of the patients with skip metastases had all LNN positive (p = 0.05).

CONCLUSION

Skip metastases occur more frequently in older patients and display certain clinicopathological features like smaller size of the primary tumor and dissemination in less lateral neck levels. In the view of the fact that they are found rather frequently, lateral neck regions should be meticulously investigated in patients with PTC without central lymph node (CLL) metastases.

摘要

背景

甲状腺乳头状癌(PTC)常发生颈部淋巴结转移,且呈阶段性转移。某些患者存在跳过中央区而首先向侧颈部转移的跳跃式转移,其意义尚未完全明确。本前瞻性研究旨在分析一组伴有侧颈部淋巴结(LLN)转移的 PTC 患者中,跳跃式转移的可能预测因子和临床病理因素。

方法

我们纳入了 2011 年至 2018 年间行全甲状腺切除术和侧颈部淋巴结清扫术的 68 例术前评估有 LLN 转移的 PTC 患者。我们分析了连续转移和跳跃转移的临床病理特征和播散模式。

结果

跳跃式转移的发生率为 23.5%。与连续转移组相比,跳跃转移组患者年龄更大,肿瘤多位于单侧,肿瘤体积更小。II 区受累较少,且跳跃转移组无一例所有侧颈部淋巴结均阳性(p=0.05)。

结论

跳跃式转移更常见于老年患者,且具有一些临床病理特征,如原发肿瘤较小,向较少的侧颈部转移。鉴于跳跃式转移较为常见,对于无中央区淋巴结(CLL)转移的 PTC 患者,应仔细检查侧颈部区域。

相似文献

1
Skip Metastases in Papillary Thyroid Carcinoma - Prevalence, Predictive and Clinicopathological Factors.甲状腺乳头状癌中的跳跃式转移——患病率、预测因素和临床病理因素。
Acta Clin Croat. 2020 Jun;59(Suppl 1):122-128. doi: 10.20471/acc.2020.59.s1.16.
2
Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.甲状腺乳头状癌的隐匿性转移在临床实践中难以预测。
BMC Cancer. 2017 Oct 25;17(1):702. doi: 10.1186/s12885-017-3698-2.
3
Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.甲状腺乳头状癌跳过中央颈部区域发生侧方淋巴结转移。
Oncotarget. 2017 Apr 18;8(16):27022-27033. doi: 10.18632/oncotarget.15388.
4
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.甲状腺乳头状癌跳跃性转移和侧颈部淋巴结转移的危险因素。
Surgery. 2019 Jul;166(1):55-60. doi: 10.1016/j.surg.2019.01.025. Epub 2019 Mar 12.
5
Predictive factors of skip metastases to lateral neck compartment leaping central neck compartment in papillary thyroid carcinoma.预测甲状腺乳头状癌向侧颈部跳跃性中央区转移的因素。
Oral Oncol. 2012 Mar;48(3):262-5. doi: 10.1016/j.oraloncology.2011.10.006. Epub 2011 Nov 1.
6
Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.甲状腺乳头状癌的侧方淋巴结转移:治疗性淋巴结清扫的结果
Thyroid. 2009 Mar;19(3):241-6. doi: 10.1089/thy.2008.0244.
7
Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.甲状腺乳头状癌侧颈淋巴结跳跃转移的危险因素及预测模型。
World J Surg. 2020 May;44(5):1498-1505. doi: 10.1007/s00268-019-05332-0.
8
Skip lateral neck node metastases in papillary thyroid carcinoma.甲状腺乳头状癌中可不清扫侧颈部淋巴结转移。
World J Surg. 2012 Apr;36(4):743-7. doi: 10.1007/s00268-012-1476-5.
9
Risk factors of skip lateral lymph node metastasis in papillary thyroid carcinoma.甲状腺乳头状癌跳跃性侧颈淋巴结转移的危险因素。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):493-498. doi: 10.1007/s00405-020-06176-4. Epub 2020 Jun 30.
10
Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌中肿瘤位置依赖性的颈侧区跳跃性淋巴结转移
Head Neck. 2014 Jun;36(6):887-91. doi: 10.1002/hed.23391. Epub 2014 Jan 13.

引用本文的文献

1
Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?对于转移性乳头状甲状腺癌患者,是否有可能排除II级和VB级淋巴结清扫?
Front Endocrinol (Lausanne). 2025 Aug 11;16:1520539. doi: 10.3389/fendo.2025.1520539. eCollection 2025.
2
Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma.列线图预测甲状腺乳头状癌中央区淋巴结转移。
Clin Exp Metastasis. 2024 Oct;41(5):613-626. doi: 10.1007/s10585-024-10285-3. Epub 2024 Apr 3.
3
Predictive Factors Affecting the Development of Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.影响甲状腺乳头状癌侧方淋巴结转移发生的预测因素
Sisli Etfal Hastan Tip Bul. 2023 Sep 29;57(3):312-319. doi: 10.14744/SEMB.2023.90235. eCollection 2023.
4
A Specificity Protein 1 assists the Progression of the Papillary Thyroid Cell Line by Initiating .特异性蛋白 1 通过起始. 辅助甲状腺乳头癌细胞系的进展。
Endocr Metab Immune Disord Drug Targets. 2024;24(7):789-797. doi: 10.2174/1871530323666230413134611.
5
[Contrast-enhanced ultrasonography with intra-glandular contrast injection can improve the diagnostic accuracy of central compartment lymph node metastasis of thyroid cancer].经腺体内注射造影剂的超声造影可提高甲状腺癌中央区淋巴结转移的诊断准确性。
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Feb 20;43(2):219-224. doi: 10.12122/j.issn.1673-4254.2023.02.09.
6
Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.预测甲状腺乳头状癌中央颈侧区大容量淋巴结转移的相关因素分析。
Front Endocrinol (Lausanne). 2022 Aug 15;13:935559. doi: 10.3389/fendo.2022.935559. eCollection 2022.
7
Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.分析影响甲状腺乳头状癌各侧颈部淋巴结转移的因素。
BMC Surg. 2022 Jun 15;22(1):228. doi: 10.1186/s12893-022-01678-w.

本文引用的文献

1
Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer.基质金属蛋白酶及其抑制剂在甲状腺乳头状癌颈淋巴结转移中的作用。
Clin Otolaryngol. 2020 Jan;45(1):55-62. doi: 10.1111/coa.13466. Epub 2019 Nov 13.
2
RET EXPRESSION AND ITS CORRELATION WITH CLINICOPATHOLOGIC DATA IN PAPILLARY THYROID CARCINOMA.甲状腺乳头状癌中RET表达及其与临床病理数据的相关性
Acta Clin Croat. 2018 Dec;57(4):646-652. doi: 10.20471/acc.2018.57.04.06.
3
Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis for prevalence, risk factors, and location.甲状腺乳头状癌侧方淋巴结转移:系统评价和荟萃分析的患病率、危险因素和位置。
Int J Surg. 2018 Feb;50:94-103. doi: 10.1016/j.ijsu.2017.12.029. Epub 2018 Jan 9.
4
Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.甲状腺乳头状癌的隐匿性转移在临床实践中难以预测。
BMC Cancer. 2017 Oct 25;17(1):702. doi: 10.1186/s12885-017-3698-2.
5
Prognosis of papillary thyroid carcinoma in elderly patients after thyroid resection: A retrospective cohort analysis.老年患者甲状腺切除术后乳头状甲状腺癌的预后:一项回顾性队列分析。
Medicine (Baltimore). 2016 Nov;95(47):e5450. doi: 10.1097/MD.0000000000005450.
6
[Parathyroid hormone values in thyroid gland surgeries by harmonic scalpel and by conventional methods].[谐波手术刀与传统方法在甲状腺手术中的甲状旁腺激素值]
Lijec Vjesn. 2013 Nov-Dec;135(11-12):306-10.
7
Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients.尿激酶型纤溶酶原激活物及其抑制剂-1 作为分化型甲状腺癌患者的预后因素。
Otolaryngol Head Neck Surg. 2013 Oct;149(4):533-40. doi: 10.1177/0194599813496374. Epub 2013 Jul 8.
8
Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌中肿瘤位置依赖性的颈侧区跳跃性淋巴结转移
Head Neck. 2014 Jun;36(6):887-91. doi: 10.1002/hed.23391. Epub 2014 Jan 13.
9
Hypocalcaemia after thyroid surgery for differentiated thyroid carcinoma: preliminary study report.分化型甲状腺癌甲状腺手术后的低钙血症:初步研究报告。
Coll Antropol. 2012 Nov;36 Suppl 2:73-8.
10
Skip metastases in papillary thyroid cancer.甲状腺乳头状癌中的跳跃性转移
Coll Antropol. 2012 Nov;36 Suppl 2:59-62.